Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota
International Immunopharmacology · 2024-10 · 140 · 112846
DOI: 10.1016/j.intimp.2024.112846 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-10. Verfasst von Li Qiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome, Flavonoids, Dextran Sulfate. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jilin Province.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a chronic inflammatory condition with recurrent and challenging symptoms. Effective treatments are lacking, making UC management a critical research area. Morin (MO), a flavonoid from the Moraceae family, shows potential as an anti-UC agent, but its mechanisms are not fully understood. Using a dextran sulfate sodium (DSS)-induced UC mouse model, we employed network pharmacology to predict MO's therapeutic effects. Assessments included changes in body weight, disease activity index (DAI), and colon length. Immunofluorescence, hematoxylin and eosin (H&E), and PAS staining evaluated colon damage. ELISA and western blot analyzed inflammatory factors, tight junction (TJ)-associated proteins (Claudin-3, Occludin, ZO-1), and Mitogen-Activated Protein Kinase (MAPK)/ Nuclear Factor kappa B (NF-κB) pathways. 16S rRNA sequencing assessed gut microbiota diversity, confirmed by MO's modulation via Fecal Microbial Transplantation (FMT). Early MO intervention reduced UC severity by improving weight, DAI scores, and colon length, increasing goblet cells, enhancing barrier function, and inhibiting MAPK/NF-κB pathways. MO enriched gut microbiota, favoring beneficial bacteria like Muribaculaceae and Erysipelotrichaceae while reducing harmful Erysipelotrichaceae and Muribaculaceae. This study highlights MO's potential in UC management through inflammation control, mucosal integrity maintenance, and gut flora modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China.
- Anorectal Department, First Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun 130021, China.
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China; Anorectal Department, Shenzhen Bao'an Authentic TCM Therapy Hospital, Shenzhen 518100, China. Electronic addres…
Förderung
- Natural Science Foundation of Jilin Province
Zitieren
APA
Qiu, L., Yan, C., Yang, Y., Liu, K., Yin, Y., Zhang, Y., Lei, Y., Jia, X., & Li, G. (2024). Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota. International Immunopharmacology, 140, 112846. https://doi.org/10.1016/j.intimp.2024.112846
Vancouver
Qiu L, Yan C, Yang Y, Liu K, Yin Y, Zhang Y, et al. Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota. International Immunopharmacology. 2024;140:112846. doi:10.1016/j.intimp.2024.112846
BibTeX
@article{Qiu2024,
author = {Qiu, Li and Yan, Chengqiu and Yang, Yue and Liu, Kunjian and Yin, Yu and Zhang, Yiwen and Lei, Yuting and Jia, Xiangwen and Li, Guofeng},
title = {Morin alleviates DSS-induced ulcerative colitis in mice via inhibition of inflammation and modulation of intestinal microbiota},
journal = {International Immunopharmacology},
year = {2024},
volume = {140},
pages = {112846},
doi = {10.1016/j.intimp.2024.112846}
}
EUVIMED